Sekėjai

Ieškoti šiame dienoraštyje

2023 m. vasario 17 d., penktadienis

This is how much time a corona infection protects against recurrence

“A corona infection protects about as well as two doses of mRNA vaccine for around ten months. Scientists report this in a meta-study. And emphasize: Vaccination remains the surest way to immunity.

One question has been hotly debated practically since the beginning of the pandemic: Does infection with SARS-CoV-2 protect against reinfection? Is Covid-19 an illness that everyone only goes through once in a lifetime? Or does the so-called natural immunity disappear quickly after infection?

It is now clear that anyone can get Covid-19 more than once. As of June 2022, it was estimated that there were around 7.63 billion infections and re-infections in the world and around half of the people had been exposed to the omicron variant.

How long exactly the immune protection lasts, researchers have determined in various works. Scientists are now presenting the most comprehensive evaluation of all studies on this topic to date in the renowned journal "The Lancet".

Studies were evaluated with subjects who had not been vaccinated against Covid-19 or in which the vaccination status could be eliminated as a factor. Overall, the health researchers analyzed 65 studies from 19 countries that were published before October 2022.

According to this, infection with a variant of the wild type or the more dangerous delta variant - i.e. before the omicron variant had spread - provided good protection against reinfection with one of these variants. One month after the initial infection, the protection was around 85 percent and still at 79 percent after ten months.

A previous infection with another variant protected less well against the omicron variant BA.1, 74 percent after one month and after ten months it was only 36 percent.

21 research papers contributed to these findings. The period of ten months was chosen for organizational reasons, since there are few long-term studies that have longer observation periods.

Six studies indicated that a first omicron infection can protect against further infection with an omicron subvariant.

 "The weaker cross-variant immunity to the omicron variant and its subgroups reflects the mutations of the virus," says Hasan Nassereldine, one of the authors of the meta-analysis.

The mutations help the virus to bypass the existing immune protection.

Vaccination remains the surest route to immunity

However, an initial infection still protects against serious illness: Five studies did not focus on pure infection, in the sense of a positive test, but on the course of the disease.

A previous infection still provided good protection against serious illness requiring hospital treatment or death from Covid-19 even after ten months. Before the wild type, the alpha or delta variant, this was 90 percent, with Omikron BA.1 it was also 88 percent.

The study has some shortcomings, as the authors point out. Because it mainly deals with pre-omicron variants. But since many people have only been infected since autumn 2022, there is still a great need for research. The study was carried out by the so-called "COVID-19 Forecasting Team". Many members, like first author Stephen Lim, belong to the Institute of Health Metrics and Evaluation's, which in turn is based at the University of Washington in Seattle. Health data is analyzed here, such as vaccination strategies. It was founded in 2007, also through a donation from the Bill & Melinda Gates Foundation.

The researchers also explain that the immune protection from infection in the first 10 months is equivalent to that from vaccination with two doses of an mRNA vaccine.

This information could influence the planning of booster shots, they say. "Vaccination is the surest way to gain immunity," says Stephen Lim. Especially for high-risk patients and older people who are at higher risk of severe disease or death. A researcher from the team emphasizes that risks have to be weighed up. The Robert Koch Institute is also dealing with the question of natural immunity and came up with contradictory results last week."


Komentarų nėra: